“`html

Nathan O. Stitziel, MD, PhD, a faculty member in medicine and genetics at Washington University School of Medicine in St. Louis, has been honored with the Harrington Discovery Institute 2025 Scholar-Innovator Award. This accolade aids in expediting innovative treatments for ailments such as cardiovascular diseases, autoimmune conditions, and cancer. He is one of 10 physician-scientists nationwide recognized this year.

Stitziel’s investigations utilize human genetic research to uncover causal genes and molecular routes that play a role in cardiovascular issues beyond cholesterol and lifestyle factors. This inquiry reveals the potential for creating novel therapies that can tackle a range of chronic ailments faced by patients. He has pinpointed various molecular pathways that, when obstructed or diminished, hold significant therapeutic implications for coronary artery disease and associated metabolic disorders. Stitziel’s recognition will particularly assist him in formulating an entirely new strategy for addressing cardiovascular illnesses by inhibiting one of these groundbreaking pathways.

Discover more on the WashU Medicine website.

The article Stitziel named scholar-innovator first appeared on The Source.

“`